BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31908143)

  • 1. The effect of inhaled corticosteroids in the outcomes of community-acquired pneumonia: ICCAP study (TURKCAP Database).
    Baha A; Kokturk N; Bahcecioglu SN; Yapar D; Aksakal N; Gündüz C; Tasbakan S; Sayiner A; Coskun AS; Durmaz F; Cilli A; Celenk B; Kılınc O; Salman S; Hazar A; Tokgoz F
    Clin Respir J; 2020 Apr; 14(4):397-404. PubMed ID: 31908143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
    Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
    Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.
    Sibila O; Laserna E; Mortensen EM; Anzueto A; Restrepo MI
    Respir Care; 2013 Sep; 58(9):1489-94. PubMed ID: 23345471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma.
    To M; To Y; Yamada H; Ogawa C; Otomo M; Suzuki N; Sano Y
    Intern Med; 2004 Aug; 43(8):674-8. PubMed ID: 15468964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia.
    Singanayagam A; Chalmers JD; Akram AR; Hill AT
    Eur Respir J; 2011 Jul; 38(1):36-41. PubMed ID: 21429980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity and outcomes of community acquired pneumonia in asthmatic patients.
    Terraneo S; Polverino E; Cilloniz C; Amaro R; Vennera Mdel C; Gabarrus A; Montull B; Moreno E; Menendez R; Centanni S; Torres A
    Respir Med; 2014 Nov; 108(11):1713-22. PubMed ID: 25245791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.
    Sellares J; López-Giraldo A; Lucena C; Cilloniz C; Amaro R; Polverino E; Ferrer M; Menéndez R; Mensa J; Torres A
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1241-8. PubMed ID: 23590264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with in-hospital mortality from community-acquired pneumonia in Portugal: 2000-2014.
    Pessoa E; Bárbara C; Viegas L; Costa A; Rosa M; Nogueira P
    BMC Pulm Med; 2020 Jan; 20(1):18. PubMed ID: 31964385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COPD on outcomes in hospitalized patients with community-acquired pneumonia: Analysis of the Spanish national hospital discharge database (2004-2013).
    de Miguel-Díez J; López-de-Andrés A; Hernández-Barrera V; Jiménez-Trujillo I; Méndez-Bailón M; de Miguel-Yanes JM; Jiménez-García R
    Eur J Intern Med; 2017 Sep; 43():69-76. PubMed ID: 28615117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
    BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    PLoS One; 2013; 8(9):e73271. PubMed ID: 24039899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids and adverse outcomes among chronic obstructive pulmonary disease patients with community-acquired pneumonia: a population-based cohort study.
    Basille D; Wang L; Thomsen RW; Menon J; Shetty N; Duhaut P; Andrejak C; Jounieaux V; Sørensen HT
    Front Med (Lausanne); 2023; 10():1184888. PubMed ID: 37554496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poverty as an independent risk factor for in-hospital mortality in community-acquired pneumonia: A study in a developing country population.
    Jahanihashemi H; Babaie M; Bijani S; Bazzazan M; Bijani B
    Int J Clin Pract; 2018 May; 72(5):e13085. PubMed ID: 29665161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.